Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgia Thomas

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Contemporary Clinical Trials|March 14, 2022
Heart failure clinical trial enrollment at a rural satellite hospitalYub Raj Sedhai, Nimesh K Patel, Virginia Mihalick, et al.
Scientific Reports|January 25, 2022
Effect of interleukin-1 blockade with anakinra on leukocyte count in patients with ST-segment elevation acute myocardial infarctionMarco Giuseppe Del Buono, Juan Ignacio Damonte, Cory R Trankle, et al.
The International Journal of Cardiovascular Imaging|January 6, 2023
Abnormal left ventricular subendocardial perfusion and diastolic function in women with obesity and heart failure and preserved ejection fractionRoshanak Markley, Marco Giuseppe Del Buono, Virginia Mihalick, et al.
Journal of Translational Medicine|June 15, 2022
Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 studyBenjamin Van Tassell, Virginia Mihalick, Georgia Thomas, et al.
Journal of Cardiovascular Pharmacology|November 25, 2020
Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II-III Systolic Heart FailureGeorge F Wohlford, Benjamin W Van Tassell, Hayley E Billingsley, et al.
Circulation. Heart Failure|December 23, 2025
Resolution of Systemic Inflammation in Patients With Recently Decompensated Heart Failure With Reduced Ejection Fraction With and Without Interleukin-1 Blockade by AnakinraBenjamin W Van Tassell, Michele Golino, Justin M Canada, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Contemporary Clinical Trials|March 14, 2022
Heart failure clinical trial enrollment at a rural satellite hospitalYub Raj Sedhai, Nimesh K Patel, Virginia Mihalick, et al.
Scientific Reports|January 25, 2022
Effect of interleukin-1 blockade with anakinra on leukocyte count in patients with ST-segment elevation acute myocardial infarctionMarco Giuseppe Del Buono, Juan Ignacio Damonte, Cory R Trankle, et al.
The International Journal of Cardiovascular Imaging|January 6, 2023
Abnormal left ventricular subendocardial perfusion and diastolic function in women with obesity and heart failure and preserved ejection fractionRoshanak Markley, Marco Giuseppe Del Buono, Virginia Mihalick, et al.
Journal of Translational Medicine|June 15, 2022
Rationale and design of interleukin-1 blockade in recently decompensated heart failure (REDHART2): a randomized, double blind, placebo controlled, single center, phase 2 studyBenjamin Van Tassell, Virginia Mihalick, Georgia Thomas, et al.
Journal of Cardiovascular Pharmacology|November 25, 2020
Phase 1B, Randomized, Double-Blinded, Dose Escalation, Single-Center, Repeat Dose Safety and Pharmacodynamics Study of the Oral NLRP3 Inhibitor Dapansutrile in Subjects With NYHA II-III Systolic Heart FailureGeorge F Wohlford, Benjamin W Van Tassell, Hayley E Billingsley, et al.
Circulation. Heart Failure|December 23, 2025
Resolution of Systemic Inflammation in Patients With Recently Decompensated Heart Failure With Reduced Ejection Fraction With and Without Interleukin-1 Blockade by AnakinraBenjamin W Van Tassell, Michele Golino, Justin M Canada, et al.
Pageof 3